Objective The risk-benefit profile of antidepressant medications in bipolar disorder is controversial. long-term trials of MG-101 prophylactic benefits have MG-101 been conducted and there is insufficient evidence for treatment benefits with antidepressants combined with mood stabilizers. A major concern is the risk for mood switch to hypomania mania and mixed states. Integrating the evidence and… Continue reading Objective The risk-benefit profile of antidepressant medications in bipolar disorder is